Topical Afimoxifene in Treating Patients With Breast Cancer Who Have Undergone Radiation Therapy on One Breast
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Cancer Survivor|Ductal Breast Carcinoma In Situ|Invasive Breast Carcinoma
Interventions: DRUG: Afimoxifene|PROCEDURE: Core Biopsy|OTHER: Questionnaire Administration
Sponsor: Northwestern University
Collaborators: National Cancer Institute (NCI)